JAZZ News and Press, Jazz Pharmaceuticals plc From 02/04/21

High-scoring, high short-interest stocks that can benefit from ongoing short covering by hedge funds as they reduce single stock risk. Institutional quality stocks with potential catalysts that support ongoing short covering, rather than flash-in-the-pan volatility. Ideas across a...

Cannabis stocks could see new highs this year. Fueling momentum, Jazz Pharmaceuticals (NASDAQ:JAZZ) said it would acquire GW Pharmaceuticals (NASDAQ:GWPH) to help strengthen its neuroscience business with GWPH’s cannabis-based epilepsy treatment. That also set in motion stren...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Going big on stimulusThe Biden administration is moving full speed ahead on a $1.9T coronavirus economic relief plan after House Democrats adopted a budget...

Are These The Best Biotech Stocks To Buy Now? 4 Names To Know Biotech stocks have been on fire in the last few months. The reason being how some of these companies delivered on investor expectations by announcing breakthrough clinical results or introduced revolutionary medicine...

Jazz Pharmaceuticals (JAZZ) raised to overweight from neutral at Piper Sandler after announcing agreement to acquire GW Pharmaceuticals (GWPH). JAZZ down 2%.``Epidiolex is the kind of durable asset that renders the potential erosion of the oxybate franchise as less problematic, positioni...

Jazz Pharmaceutical s (NASDAQ: JAZZ) announced a $7.6 billion deal to acquire GW Pharmaceuticals (NASDAQ: GWPH) , a British biotech company focused on drugs derived from cannabis. The unexpected news sent shares of GW Pharmaceuticals soaring 46%. Under the terms of the a...

Delta, Kelowna, BC - February 3, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus ins...

With its $7.2B acquisition of GW Pharmaceuticals (GWPH), Jazz Pharmaceuticals (JAZZ) has acquired more than just GW's key cannabinoid product, Epidiolex, for seizures in certain conditions.Based on preliminary figures, sales of Epidiolex were around $510M in 2020.The most advanced cannabinoid...

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) and GW Pharmaceuticals plc (NASDAQ: GWPH) reported entry into a definitive agreement where Jazz will acquire GW for USD 220 per American Depositary Share as USD 200 in cash and USD 20 in Jazz ordinary shares for a total of USD 7....

Shares of GW Pharmaceuticals (NASDAQ: GWPH) were skyrocketing 46.3% as of 10:45 a.m. EST on Wednesday. The huge gain came after Jazz Pharmaceuticals (NASDAQ: JAZZ) announced plans to acquire GW for $7.2 billion. It's certainly not surprising in the least that GW Pharmace...